-
Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer
03 Jun 2024 18:48 GMT
… advanced osimertinib-resistant EGFR-mutated lung cancer,” was presented by Turja Chakrabarti … the FDA in combination with capecitabine for the treatment of adult … with extensive-stage small cell lung cancer.
Further information about Puma Biotechnology …
-
Bevacizumab by F. Hoffmann-La Roche for Small-Cell Lung Cancer: Likelihood of Approval
17 May 2024 03:08 GMT
… Avastin in combination with xeloda or paclitaxel is indicated … squamous non-small cell lung cancer (with carboplatin and … carcinoma, non-small cell lung cancer, metastatic colorectal cancer, … adjuvant non small cell lung cancer (NSCLC), metastatic liver …
-
Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer or HR Positive, HER2 Negative Breast Cancer
04 Mar 2024 10:29 GMT
… nonsquamous non-small cell lung cancer (NSCLC) who … -agent chemotherapy (eribulin, capecitabine, vinorelbine or gemcitabine) … Small Cell Lung Cancer
Nearly 500,000 lung cancer cases were … References:
1 Cancer.net. Lung Cancer – Non-Small Cell: Statistics …
-
Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer
13 Feb 2024 13:43 GMT
… for alisertib in small cell lung cancer.
“Treatment options for … of alisertib in small cell lung cancer and, more specifically, … FDA in combination with capecitabine for the treatment of … the treatment of small cell lung cancer and breast cancer.
Further …
-
Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs
10 Jul 2024 18:05 GMT
… of neoadjuvant treatment with capecitabine plus temozolomide (CAPTEM) … to 2% of all lung cancers.1 They are sporadic … oligometastatic non-small-cell lung cancer without progression after first … for atypical bronchopulmonary carcinoids. Lung Cancer, 90-94, doi: …
-
Biomarker-Guided Treatment Approaches Transform Lung and GI Cancer Management
13 Dec 2024 20:00 GMT
… CRC), non–small cell lung cancer (NSCLC), and gastric cancer … know about from melanoma, lung cancer, and cholangiocarcinoma, exist in … addition of zolbetuximab to capecitabine [Xeloda] and oxaliplatin [CAPOX] … the GI and Lung Cancer Biomarker Consortiums, click …
-
Paving the Way for Better Outcomes in HER2+ Early Breast Cancer Treatment
13 Dec 2024 11:10 GMT
… , gastric, and non–small cell lung cancers. Key trial data, including the … vs. placebo in combination with capecitabine & trastuzumab in patients with …
-
Puma Biotechnology Receives FDA Orphan Drug Designation for Alisertib for the Treatment of Small Cell Lung Cancer
21 Sep 2023 20:17 GMT
… of patients with small cell lung cancer (SCLC). SCLC is an … the treatment of small cell lung cancer,” said Alan H. Auerbach, … the FDA in combination with capecitabine for the treatment of … the treatment of small cell lung cancer and breast cancer.
Further …
-
Puma Biotechnology Announces FDA Clearance of IND for Alisertib in Small Cell Lung Cancer
08 Aug 2023 12:35 GMT
… extensive stage small cell lung cancer who have progressed after … for alisertib in small cell lung cancer.
“Treatment options for … FDA in combination with capecitabine for the treatment of … the treatment of small cell lung cancer and breast cancer.
Further …
-
Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in HER2-Positive Breast Cancer with Brain Metastases
23 Mar 2024 10:09 GMT
… of metastasis, following lung cancer, accounting for 15 … that pyrotinib and capecitabine combination therapy effectively … conclusion, pyrotinib and capecitabine combination therapy demonstrated … plus capecitabine versus lapatinib plus capecitabine in HER2 …